{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T07:11:04Z","timestamp":1760425864149,"version":"build-2065373602"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,13]]},"DOI":"10.7759\/cureus.94516","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T06:28:16Z","timestamp":1760423296000},"source":"Crossref","is-referenced-by-count":0,"title":["Subacute Infective Endocarditis Misdiagnosed as Polymyalgia Rheumatica: A Case Report"],"prefix":"10.7759","author":[{"given":"Zorab","family":"Rahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Eftekhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213883","article-title":"Incidence, prevalence and treatment burden of polymyalgia rheumatica in the UK over two decades: a population-based study","volume":"77","author":"Partington RJ","year":"2018","unstructured":"Partington RJ, Muller S, Helliwell T, Mallen CD, Abdul Sultan A. Incidence, prevalence and treatment burden of polymyalgia rheumatica in the UK over two decades: a population-based study. Ann Rheum Dis. 2018, 77:1750-6. 10.1136\/annrheumdis-2018-213883","journal-title":"Ann Rheum Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151103","article-title":"Assessment of the new 2012 EULAR\/ACR clinical classification criteria for polymyalgia rheumatica: a prospective multicenter study","volume":"43","author":"Ozen G","year":"2016","unstructured":"Ozen G, Inanc N, Unal AU, et al.. Assessment of the new 2012 EULAR\/ACR clinical classification criteria for polymyalgia rheumatica: a prospective multicenter study. J Rheumatol. 2016, 43:893-900. 10.3899\/jrheum.151103","journal-title":"J Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.cme.20.1.1","article-title":"Infective endocarditis: a contemporary update","volume":"20","author":"Rajani R","year":"2020","unstructured":"Rajani R, Klein JL. Infective endocarditis: a contemporary update. Clin Med (Lond). 2020, 20:31-5. 10.7861\/clinmed.cme.20.1.1","journal-title":"Clin Med (Lond)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-87-6-754","article-title":"Musculoskeletal manifestations of bacterial endocarditis","volume":"87","author":"Churchill MA Jr","year":"1977","unstructured":"Churchill MA Jr, Geraci JE, Hunder GG. Musculoskeletal manifestations of bacterial endocarditis. Ann Intern Med. 1977, 87:754-9. 10.7326\/0003-4819-87-6-754","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad193","article-title":"2023 ESC guidelines for the management of endocarditis","volume":"44","author":"Delgado V","year":"2023","unstructured":"Delgado V, Ajmone Marsan N, de Waha S, et al.. 2023 ESC guidelines for the management of endocarditis. Eur Heart J. 2023, 44:3948-4042. 10.1093\/eurheartj\/ehad193","journal-title":"Eur Heart J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad271","article-title":"The 2023 Duke-International Society for Cardiovascular Infectious Diseases criteria for infective endocarditis: updating the modified Duke criteria","volume":"77","author":"Fowler VG","year":"2023","unstructured":"Fowler VG, Durack DT, Selton-Suty C, et al.. The 2023 Duke-International Society for Cardiovascular Infectious Diseases criteria for infective endocarditis: updating the modified Duke criteria. Clin Infect Dis. 2023, 77:518-26. 10.1093\/cid\/ciad271","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200101000-00002","article-title":"Rheumatic manifestations of infective endocarditis in non-addicts: a 12-year study","volume":"80","author":"Gonz\u00e1lez-Juanatey C","year":"2001","unstructured":"Gonz\u00e1lez-Juanatey C, Gonz\u00e1lez-Gay MA, Llorca J, et al.. Rheumatic manifestations of infective endocarditis in non-addicts: a 12-year study. Medicine (Baltimore). 2001, 80:9-19. 10.1097\/00005792-200101000-00002","journal-title":"Medicine (Baltimore)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2008.603","article-title":"Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis - prospective cohort study","volume":"169","author":"Murdoch DR","year":"2009","unstructured":"Murdoch DR, Corey GR, Hoen B, et al.. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis - prospective cohort study. Arch Intern Med. 2009, 169:463-73. 10.1001\/archinternmed.2008.603","journal-title":"Arch Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223335","article-title":"2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases","volume":"82","author":"Fragoulis GE","year":"2023","unstructured":"Fragoulis GE, Nikiphorou E, Dey M, et al.. 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2023, 82:742-53. 10.1136\/ard-2022-223335","journal-title":"Ann Rheum Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2016.1235282","article-title":"Time interval between infective endocarditis first symptoms and diagnosis: relationship to infective endocarditis characteristics, microorganisms and prognosis","volume":"49","author":"N'Guyen Y","year":"2017","unstructured":"N'Guyen Y, Duval X, Revest M, et al.. Time interval between infective endocarditis first symptoms and diagnosis: relationship to infective endocarditis characteristics, microorganisms and prognosis. Ann Med. 2017, 49:117-25. 10.1080\/07853890.2016.1235282","journal-title":"Ann Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/ard.38.5.434","article-title":"An evaluation of criteria for polymyalgia rheumatica","volume":"38","author":"Bird HA","year":"1979","unstructured":"Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis. 1979, 38:434-9. 10.1136\/ard.38.5.434","journal-title":"Ann Rheum Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/014107680109400513","article-title":"Polymyalgia rheumatica: pitfalls in diagnosis","volume":"94","author":"Siebert S","year":"2001","unstructured":"Siebert S, Lawson TM, Wheeler MH, Martin JC, Williams BD. Polymyalgia rheumatica: pitfalls in diagnosis. J R Soc Med. 2001, 94:242-4. 10.1177\/014107680109400513","journal-title":"J R Soc Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/412859-subacute-infective-endocarditis-misdiagnosed-as-polymyalgia-rheumatica-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T06:28:16Z","timestamp":1760423296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/412859-subacute-infective-endocarditis-misdiagnosed-as-polymyalgia-rheumatica-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.94516","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,13]]}}}